Literature DB >> 24520539

Breast cancer and protein biomarkers.

Lay-Harn Gam1.   

Abstract

Breast cancer is a healthcare concern of women worldwide. Despite procedures being available for diagnosis, prognosis and treatment of breast cancer, researchers are working intensively on the disease in order to improve the life quality of breast cancer patients. At present, there is no single treatment known to bring a definite cure for breast cancer. One of the possible solutions for combating breast cancer is through identification of reliable protein biomarkers that can be effectively used for early detection, prognosis and treatments of the cancer. Therefore, the task of identification of biomarkers for breast cancer has become the focus of many researchers worldwide.

Entities:  

Keywords:  Biomarkers; Breast cancer; Protein; Proteomics

Year:  2012        PMID: 24520539      PMCID: PMC3905586          DOI: 10.5493/wjem.v2.i5.86

Source DB:  PubMed          Journal:  World J Exp Med        ISSN: 2220-315X


  43 in total

Review 1.  Proteomics for cancer biomarker discovery.

Authors:  Pothur R Srinivas; Mukesh Verma; Yinming Zhao; Sudhir Srivastava
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

2.  Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure.

Authors:  Chafika Mazouni; Keith Baggerly; David Hawke; Spyros Tsavachidis; Fabrice André; Aman U Buzdar; Pierre-Marie Martin; Ryuji Kobayashi; Lajos Pusztai
Journal:  Proteomics       Date:  2010-10       Impact factor: 3.984

3.  Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.

Authors:  Robert L Stout; Michael Fulks; Vera F Dolan; Mark E Magee; Luis Suarez
Journal:  J Insur Med       Date:  2007

4.  Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.

Authors:  Daohai Zhang; Thomas C Putti
Journal:  Exp Cell Res       Date:  2010-09-15       Impact factor: 3.905

5.  Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.

Authors:  Juan Du; Qiang Du; Yang Zhang; Constantin Sajdik; Yuan Ruan; Xin-xia Tian; Wei-gang Fang
Journal:  Histol Histopathol       Date:  2011-06       Impact factor: 2.303

Review 6.  Biomarkers for early detection of breast cancer: what, when, and where?

Authors:  Victor V Levenson
Journal:  Biochim Biophys Acta       Date:  2007-02-12

7.  Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.

Authors:  Eloisi Caldas-Lopes; Leandro Cerchietti; James H Ahn; Cristina C Clement; Ana I Robles; Anna Rodina; Kamalika Moulick; Tony Taldone; Alexander Gozman; Yunke Guo; Nian Wu; Elisa de Stanchina; Julie White; Steven S Gross; Yuliang Ma; Lyuba Varticovski; Ari Melnick; Gabriela Chiosis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-05       Impact factor: 11.205

8.  The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.

Authors:  Vivien D'Arcy; Ziedulla K Abdullaev; Naresh Pore; France Docquier; Verónica Torrano; Igor Chernukhin; Melissa Smart; Dawn Farrar; Metodi Metodiev; Nelson Fernandez; Carlos Richard; M Dolores Delgado; Victor Lobanenkov; Elena Klenova
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

Review 9.  CA 125: the past and the future.

Authors:  R C Bast; F J Xu; Y H Yu; S Barnhill; Z Zhang; G B Mills
Journal:  Int J Biol Markers       Date:  1998 Oct-Dec       Impact factor: 3.248

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more
  4 in total

Review 1.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

2.  Exploring the endogenous potential of Hemidesmus indicus against breast cancer using in silico studies and quantification of 2-hydroxy-4-methoxy benzaldehyde through RP-HPLC.

Authors:  Akash Anand Bansod; Gnanam Ramasamy; Bharathi Nathan; Rajamani Kandhasamy; Meenakshisundaram Palaniappan; Santhanakrishnan Vichangal Pridiuldi
Journal:  3 Biotech       Date:  2021-04-24       Impact factor: 2.406

Review 3.  On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system.

Authors:  Tobore Onojighofia Tobore
Journal:  Future Sci OA       Date:  2019-11-29

Review 4.  Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.

Authors:  Chris Vi; Giovanni Mandarano; Sarah Shigdar
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.